Pragmatic Options for Antiretrovirals Delivery in Africa is a Phase III parallel‑group, open‑label, multi‑country, multi‑centre randomised controlled trial evaluating the effectiveness, safety and implementability of new and simplified anti-retroviral therapy for long-term HIV treatment.   The trial is coordinated by the University of St Andrews, with support from the University of Liverpool and Università degli Studi di Torino, and is being conducted in Uganda, Kenya, Côte d’Ivoire, and Zimbabwe to compare this regimen with standard first‑line treatment in adults who are already virologically suppressed. Feasibility, safety, and cost‑effectiveness will also be assessed to inform potential integration of this regimen into routine HIV care.

POA Logo

Funders

This project is funded by:

Partners

University of St Andrews, UK – Coordinator
Infectious Diseases Institute Limited, Uganda – Sponsor and Scientific lead
University of Zimbabwe, Zimbabwe
MOI University, Kenya
Association PAC-CI, Ivory Coast
University of Liverpool, UK
Universita Degli Studi de Torino, Italy

Team

Dr Derek Sloan
Margaret Borok

Prof Margaret Borok

University of Zimbabwe

Dr Albert Kla Minga

PAC-CI, Côte d’Ivoire

Dr. Raoul D. Moh

PAC-CI, Côte d’Ivoire

Dr Stéphane N’GORAN

PAC-CI, Côte d’Ivoire

Dr Amedeo De Nicolò

University of Turin, Italy

Dr Christine Sekaggya-Wiltshire

Infectious Diseases Institute, Uganda

Prof Catriona Waitt

University of Liverpool

X